Is Informed Consent a One-Time Event or an Ongoing Process?

Does Consent End Once the Participant Signs?

A participant reads the information sheet, asks a few questions, signs the consent form, and enters the study. Has the researcher now finished obtaining informed consent?

Not quite. The signature may document an important decision at a particular point in time, but it does not turn that decision into permanent permission regardless of what happens afterward. A participant may receive new information, encounter procedures differently from what they expected, develop new questions, or simply decide that continuing is no longer right for them.

This distinction matters because researchers sometimes treat the consent form and informed consent as though they were the same thing. They are related, but they are not interchangeable.

Informed Consent Continues Beyond the Signature

Why Informed Consent Is Better Understood as a Process

The Consent Form and the Consent Process Are Not the Same Thing

A consent form is primarily a means of presenting information and, when required, documenting consent. The broader consent process concerns the communication and decision-making that make the participant's agreement genuinely informed and voluntary.

The U.S. Office for Human Research Protections (OHRP), for example, describes informed consent as a communication process that begins with the investigator's initial approach to a potential participant and continues until completion of the research. OHRP also emphasizes that a signed form by itself does not constitute an adequate consent process.

The ethical reasoning is straightforward. A signature can show that someone agreed at a particular moment. It cannot establish that the person will remain adequately informed and willing throughout everything that follows.

Initial Consent Is Still an Important Decision Point

Calling consent an ongoing process does not make the initial consent unimportant. Before a person is enrolled in research, the researcher ordinarily needs to provide the information required by the applicable ethical and regulatory framework, support adequate understanding, allow sufficient opportunity for questions and consideration, and ensure that the decision is voluntary.

The initial decision therefore matters greatly. The mistake is treating it as the final ethically relevant decision the participant will ever make about the study.

Participation Remains Voluntary After Enrollment

Voluntariness is not relevant only when someone is deciding whether to join. A participant who initially agrees does not surrender the ability to reconsider that decision.

Under the U.S. Common Rule, required consent information includes a statement that participation is voluntary and that a participant may discontinue participation without penalty or loss of benefits to which they are otherwise entitled. The 2024 World Medical Association Declaration of Helsinki similarly states that participants in medical research must be informed of their right to refuse participation or withdraw consent at any time without reprisal.

This is why a participant's later decisions matter. Someone can change their mind after initially agreeing. The original signature does not override a later decision to stop.

Information Relevant to the Decision Can Change

Consent is based on information available when the participant makes a decision. Research, however, can unfold over weeks, months, or years. Relevant circumstances may change during that period.

For research governed by the U.S. Common Rule, one of the additional elements of informed consent, when appropriate, is a statement that significant new findings developed during the research that may relate to a participant's willingness to continue will be provided to that participant. This captures an important principle: information that could reasonably affect the decision to remain in a study should not simply remain with the research team.

New information might concern risks, procedures, alternatives, or other aspects of participation. Whether a particular development requires a formal new consent procedure is a more specific question. The important point here is that an earlier consent does not make later decision-relevant information irrelevant.

When new risks are discovered, for example, researchers need to consider whether and how that information should be communicated to participants under the applicable protocol, ethics approval, regulations, and institutional requirements.

Ongoing Consent Does Not Mean Signing a Form at Every Visit

This is an important boundary. If consent is ongoing, it may sound as though researchers must formally obtain consent again before every interview, survey, blood draw, follow-up visit, or study activity. That is not what the principle means.

Ongoing consent is broader than repeated documentation. In a stable study, continuing the consent process may involve remaining available for questions, reminding participants of relevant choices when appropriate, communicating material new information, paying attention to whether participation remains voluntary, and responding appropriately if circumstances change.

Formal reconsent is a separate issue. Some developments may justify or require participants to go through a renewed consent procedure, whereas ordinary continuation of an unchanged study may not. The question of when participants should be asked to consent again therefore requires a more specific assessment than simply saying that consent is ongoing.

Ongoing Consent Is Not Identical in Every Study

The practical intensity of the consent process should reflect the research. A one-time anonymous questionnaire completed in ten minutes presents a very different consent context from a multi-year clinical trial involving repeated interventions and evolving safety information.

In a short, simple study, there may be little opportunity or need for additional consent-related communication after the participant begins. In longitudinal, complex, higher-risk, or changing research, maintaining meaningful consent may require considerably more attention.

Researchers should also avoid treating one jurisdiction's regulatory requirements as universal. The exact obligations concerning consent, documentation, reconsent, ethics review, and withdrawal can differ according to applicable law, regulatory framework, institution, research setting, and study design. The relevant research ethics committee or institutional review board should be consulted when formal requirements are uncertain.

Understanding and Willingness Can Also Change

Nothing about signing a document guarantees that a participant will remember every study detail indefinitely. This becomes particularly relevant in long or complicated studies. Researchers should not assume that a signature from months earlier proves current understanding of everything that matters now.

That does not mean participants must repeatedly pass a test on the protocol. Rather, researchers should be alert to situations in which misunderstanding becomes apparent or in which the participant may need information again to make a meaningful decision about what happens next. If a participant appears to have forgotten what they agreed to, the appropriate response depends on what has been forgotten and whether it affects informed participation.

Willingness can be similarly dynamic. A participant may comply with study procedures while showing hesitation, reluctance, or discomfort. Researchers should not automatically equate the absence of an explicit withdrawal statement with enthusiastic continuing agreement. Situations in which a participant no longer seems comfortable participating deserve careful attention rather than mechanical reliance on the original form.

Capacity Can Change Too

For some studies, particularly long-term research involving illness, aging, injury, or conditions affecting cognition, a participant's decision-making capacity may change during the study. An earlier valid consent does not by itself answer every ethical or legal question that arises after such a change.

The appropriate response depends on the study, the participant's condition, applicable law, the approved protocol, and the relevant ethics framework. Researchers facing loss of capacity during ongoing data collection should therefore follow the approved procedures and applicable requirements rather than assuming that the original consent automatically authorizes everything planned for the remainder of the study.

What Ongoing Consent Can Look Like in a Longitudinal Study

Common Misunderstandings About Ongoing Informed Consent

Treat Consent as a Relationship With Decision Points, Not a Completed Form

For researchers, the practical shift is modest but important. Do not think of consent as a box that becomes permanently checked on enrollment day. Think instead about whether participants continue to have the information and freedom needed to make meaningful decisions about their involvement when those decisions arise.

Formal requirements vary, so your protocol, consent materials, ethics approval, institutional policies, and applicable regulations remain important. The ongoing-process principle does not replace those requirements. It helps explain what informed consent is supposed to protect.

Is Your Consent Process Really Continuing?

Questions About Consent After a Study Has Started

A Signature Records a Decision; It Does Not End the Consent Process

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.